Hexaquine


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 44.8%
Product Used For Unknown Indication 19.8%
Breast Cancer 4.7%
Hiv Infection 3.9%
Premedication 3.4%
Muscle Spasms 3.0%
Analgesic Asthma Syndrome 2.6%
Hypereosinophilic Syndrome 2.6%
Hypertension 2.6%
Fall 1.7%
Restless Legs Syndrome 1.7%
Depression 1.3%
Hiv Antigen Positive 1.3%
Prophylaxis 1.3%
Alcoholism 0.9%
Arteritis Coronary 0.9%
Asthma 0.9%
Atrial Fibrillation 0.9%
Convulsion 0.9%
Diabetes Mellitus 0.9%
Thrombocytopenic Purpura 17.8%
Anaemia Haemolytic Autoimmune 8.9%
Somnolence 8.9%
Allergic Granulomatous Angiitis 6.7%
Thrombocytopenia 6.7%
Hepatitis 4.4%
Hypertension 4.4%
Lung Disorder 4.4%
Multi-organ Failure 4.4%
Pityriasis Rosea 4.4%
Pyrexia 4.4%
Renal Failure 4.4%
Sinusitis 4.4%
Acute Respiratory Distress Syndrome 2.2%
Bone Marrow Failure 2.2%
Cardiac Arrest 2.2%
Diarrhoea 2.2%
Electrocardiogram Qt Prolonged 2.2%
Haemolytic Uraemic Syndrome 2.2%
Hypercapnia 2.2%
Concomitant
Drug Use For Unknown Indication 30.8%
Product Used For Unknown Indication 16.8%
Hypertension 10.0%
Muscle Spasms 6.1%
Prophylaxis 3.5%
Anxiety 3.1%
Pain 2.9%
Parkinson's Disease 2.8%
Multiple Myeloma 2.6%
Osteoporosis 2.6%
Gastrooesophageal Reflux Disease 2.4%
Insomnia 2.4%
Neuralgia 2.2%
Bronchitis 1.9%
Neuropathy Peripheral 1.9%
Crohn's Disease 1.7%
Hepatitis C 1.7%
Plasma Cell Myeloma 1.6%
Unevaluable Event 1.6%
Hypercholesterolaemia 1.4%
Renal Failure Acute 9.3%
Renal Failure 8.0%
Rhabdomyolysis 8.0%
Vomiting 8.0%
Weight Decreased 8.0%
Anal Cancer 5.3%
Left Ventricular Failure 5.3%
Suicide Attempt 5.3%
Thrombocytopenia 5.3%
Agranulocytosis 4.0%
Amaurosis Fugax 4.0%
Overdose 4.0%
Platelet Count Increased 4.0%
Septic Shock 4.0%
Urticaria 4.0%
Atrial Fibrillation 2.7%
Cerebral Infarction 2.7%
Chest Pain 2.7%
Confusional State 2.7%
Cytolytic Hepatitis 2.7%

Drug Data